Phase 3 Multicenter Randomized Double-Blind, Double-dummy, Active-Controlled Study Comparing Efficacy/Safety of Gastric-retentive, Controlled-release Accordion Pill Carbidopa/Levodopa to Immediate Release in Fluctuating Parkinson's Patients
Phase of Trial: Phase III
Latest Information Update: 20 Apr 2018
At a glance
- Drugs Levodopa/carbidopa (Primary) ; Levodopa/carbidopa
- Indications Parkinson's disease
- Focus Registrational; Therapeutic Use
- Acronyms Accordance
- Sponsors Intec Pharma
- 13 Apr 2018 Planned End Date changed from 1 Jun 2018 to 1 Sep 2018.
- 13 Apr 2018 Planned primary completion date changed from 1 Jun 2018 to 1 Sep 2018.
- 09 Mar 2018 According to an Intec Pharma media release, more than 300 patients enrolled to date in this pivotal Phase 3 trial.